{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:01:31Z","timestamp":1761058891845},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.4065\/79.12.1557","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:23:48Z","timestamp":1232760228000},"page":"1557-1561","source":"Crossref","is-referenced-by-count":15,"title":["Osteoporosis Associated With Megestrol Acetate"],"prefix":"10.4065","volume":"79","author":[{"given":"Robert A.","family":"Wermers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann E.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/79.12.1557_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/archinte.1997.00440360053005","article-title":"Glucocorticoidlike activity of megestrol: a summary of Food and Drug Administration experience and a review of the literature","volume":"157","author":"Mann","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.4065\/79.12.1557_bib2","first-page":"1515","article-title":"Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients","volume":"2","author":"Lundgren","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.4065\/79.12.1557_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0277-5379(84)90031-2","article-title":"Treatment of metastatic breast cancer patients with different dosages of megestrol acetate: dose relations, metabolic and endocrine effects","volume":"20","author":"Alexieva-Figusch","year":"1984","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.4065\/79.12.1557_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1530\/acta.0.0780574","article-title":"Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands","volume":"78","author":"Kontula","year":"1975","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4065\/79.12.1557_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/acta.0.0430477","article-title":"The cortisone-like effect of 6\u03b1-methyl-17\u03b1-acetoxyprogesterone in the adrenalectomized man","volume":"43","author":"Camanni","year":"1963","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4065\/79.12.1557_bib6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0006-2952(83)90474-4","article-title":"Binding of progestins to the glucocorticoid receptor: correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes","volume":"32","author":"Kontula","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.4065\/79.12.1557_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00007890-196803000-00010","article-title":"Immunosuppression with medroxyprogesterone acetate","volume":"6","author":"Turcotte","year":"1968","journal-title":"Transplantation"},{"key":"10.4065\/79.12.1557_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2265.1995.tb02603.x","article-title":"Megestrol-induced Cushing's syndrome","volume":"42","author":"Steer","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4065\/79.12.1557_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-111-9-758","article-title":"The Cushing syndrome induced by medroxyprogesterone acetate","volume":"111","author":"Siminoski","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.12.1557_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0277-5379(90)90231-H","article-title":"A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer","volume":"26","author":"Willemse","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.4065\/79.12.1557_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1200\/JCO.1993.11.1.152","article-title":"Body-composition changes in patients who gain weight while receiving megestrol acetate","volume":"11","author":"Loprinzi","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.4065\/79.12.1557_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/108729100416614","article-title":"Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate","volume":"14","author":"Koller","year":"2000","journal-title":"AIDS Patient Care STDS"},{"key":"10.4065\/79.12.1557_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0277-5379(90)90234-K","article-title":"Adrenal steroids as parameters of the bioavailability of MA and MPA","volume":"26","author":"Willemse","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.4065\/79.12.1557_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0039-128X(73)90011-1","article-title":"Glucocorticoid properties of progestogens","volume":"22","author":"Briggs","year":"1973","journal-title":"Steroids"},{"key":"10.4065\/79.12.1557_bib15","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0025-6196(12)61145-8","article-title":"Effect of megestrol acetate on the human pituitary-adrenal axis","volume":"67","author":"Loprinzi","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/79.12.1557_bib16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/82.13.1127","article-title":"Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia","volume":"82","author":"Loprinzi","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/79.12.1557_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JCO.1996.14.1.135","article-title":"Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate\/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study","volume":"14","author":"Rowland","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.4065\/79.12.1557_bib18","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1210\/jc.86.12.5681","article-title":"Glucocorticoid-induced osteoporosis: summary of a workshop","volume":"86","author":"Canalis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/79.12.1557_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa002304","article-title":"Effects of inhaled glucocorticoids on bone density in premenopausal women","volume":"345","author":"Israel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4065\/79.12.1557_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","article-title":"Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease","volume":"120","author":"Zelissen","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.12.1557_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.4065\/79.12.1557_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1359\/jbmr.2002.17.1.172","article-title":"Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women","volume":"17","author":"Heshmati","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.4065\/79.12.1557_bib23","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.83.7.2239","article-title":"Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures","volume":"83","author":"Ettinger","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/79.12.1557_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199809103391104","article-title":"Endogenous hormones and the risk of hip and vertebral fractures among older women","volume":"339","author":"Cummings","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/79.12.1557_bib25","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1359\/jbmr.2003.18.5.900","article-title":"Fracture risk after bilateral oophorectomy in elderly women","volume":"18","author":"Melton","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.4065\/79.12.1557_bib26","first-page":"3485","article-title":"Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate","volume":"23","author":"Martinetti","year":"2003","journal-title":"Anticancer Res"},{"issue":"2, suppl 1","key":"10.4065\/79.12.1557_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","article-title":"Side effects of androgen deprivation therapy: monitoring and minimizing toxicity","volume":"61","author":"Higano","year":"2003","journal-title":"Urology"},{"issue":"9, suppl","key":"10.4065\/79.12.1557_bib28","first-page":"795","article-title":"Bone mineral density and DMPA","volume":"47","author":"Westhoff","year":"2002","journal-title":"J Reprod Med"},{"key":"10.4065\/79.12.1557_bib29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0015-0282(03)02166-6","article-title":"Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial","volume":"80","author":"Carr","year":"2003","journal-title":"Fertil Steril"},{"key":"10.4065\/79.12.1557_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/edrv-11-2-386","article-title":"Progesterone as a bone-trophic hormone","volume":"11","author":"Prior","year":"1990","journal-title":"Endocr Rev"},{"key":"10.4065\/79.12.1557_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/acta.0.1260329","article-title":"Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-2 production","volume":"126","author":"Tremollieres","year":"1992","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4065\/79.12.1557_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF00301947","article-title":"Progesterone receptors are expressed in human osteoblast-like cell lines and in primary human osteoblast cultures","volume":"57","author":"MacNamara","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"10.4065\/79.12.1557_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S8756-3282(96)00315-8","article-title":"Progesterone stimulates proliferation and differentiation of osteoprogenitor cells in bone cell populations derived from adult female but not from adult male rats","volume":"20","author":"Ishida","year":"1997","journal-title":"Bone"},{"key":"10.4065\/79.12.1557_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2265.1993.tb02422.x","article-title":"Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis","volume":"39","author":"Horowitz","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4065\/79.12.1557_bib35","first-page":"1","article-title":"Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women","volume":"63","author":"Lobo","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.4065\/79.12.1557_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9343(91)90538-9","article-title":"Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen","volume":"90","author":"Gallagher","year":"1991","journal-title":"Am J Med"},{"key":"10.4065\/79.12.1557_bib37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4065\/75.8.821","article-title":"Prevention and treatment of osteoporosis in women with breast cancer [published correction appears in Mayo Clin Proc. 2001;76:113]","volume":"75","author":"Mincey","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"suppl 2","key":"10.4065\/79.12.1557_bib38","first-page":"S22","article-title":"Increased fracture risk among breast cancer survivors: results from the Women's Health Initiative [abstract]","volume":"18","author":"Chen","year":"2003","journal-title":"J Bone Miner Res"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611618624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611618624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T14:02:58Z","timestamp":1558101778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611618624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0025619611618624"],"URL":"https:\/\/doi.org\/10.4065\/79.12.1557","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}